Evidence map›Paper›PMID 29152113›Full record

ArticleOncotarget2017

The prognostic significance of

Chen Xu, Yalan Liu, Jie Huang, Hao Wang, Lijie Tan, Yifan Xu, Zhengzeng Jiang, Xin Wang, Yingyong Hou, Dongxian Jiang and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mitochondrial Involvement in Migration, Invasion and Metastasis.Frontiers in cell and developmental biology · 2019
    Review
  5. MCL-1 inhibition in cancer treatment.OncoTargets and therapy · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Chen Xu *Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Yalan Liu *Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Jie HuangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Hao WangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Lijie TanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Yifan XuDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Zhengzeng JiangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Xin WangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Yingyong HouDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Dongxian JiangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Qun WangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Sun Yat-sen University · CNFudan University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsFluorescence

resultsThe median age of ESCC patients was 62 years (range 37-83), with frequencies between women (16.4%) and men (83.6%). Of the 262 tumors, 77 tumors (29.4%) had high

conclusionWe observed that high

Indexed as

clinical stageESCClymph node metastasisMCL1 copy number gainprognostic marker

Identifiers

PMID29152113
PMCPMC5675665
OpenAlexW2758501871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.